Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1

Molecular and Cellular Biology

Volumn 22, Issue 11, 2002, Pages 3729-3743

  Hong, Wei ^a   Kim, Alexander Y ^a   Ky, Sokun ^a   Rakowski, Carrie ^a   Seo, Sang Beom ^a   Chakravarti, Debabrata ^a   Atchison, Michael ^a   Blobel, Gerd A ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; COACTIVATOR PROTEIN CBP; ERYTHROID KRUPPEL LIKE FACTOR; HISTONE; NUCLEAR PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROLEUKEMIA CELL; GENE LOCUS; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

3T3 CELLS; ACETYLATION; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; DNA; DNA-BINDING PROTEINS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; GATA1 TRANSCRIPTION FACTOR; GLOBINS; HISTONES; MICE; NF-E2 TRANSCRIPTION FACTOR; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

ANIMALIA; MURINAE;

EID: 0036094806     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.11.3729-3743.2002     Document Type: Article

References (86)

1. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A
2. Recruitment of p300/CBP in p53-dependent signal pathways
3. The CBP co-activator is a histone acetyltransferase
4. Erythroleukemia induction by Friend murine leukemia virus: Insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1
5. The erythroid Krüppel-like factor transactivation domain is a critical component for the cell-specific inducibility of a β-globin promoter
6. The maf transcription factors: Regulators of differentiation
7. Human MafG is a functional partner for p45 NF-E2 in activating globin gene expression
8. CBP/p300: Molecular integrators of hematopoietic transcription
9. CREB-binding protein (CBP) cooperates with transcription factor GATA-1 and is required for erythroid differentiation
10. Regulation of activity of the transcription factor GATA-1 by acetylation
11. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity
12. p300/CBP proteins: HATs for transcriptional bridges and scaffolds
13. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B
14. The transcriptional integrator CREB-binding protein mediates positive cross talk between nuclear hormone receptors and the hematopoietic bZip protein p45/NF-E2
15. Regulation of B lymphocyte and macrophage development by graded expression of PU.1
16. Role of PU.1 in hematopoiesis
17. Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain
18. Requirement of an E1A-sensitive coactivator for long-range transactivation by the β-globin locus control region
19. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1
20. Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis
21. CBP/p300 in cell growth, transformation, and development
22. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
23. Synergistic activation of transcription by CBP and p53
24. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB
25. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A
26. Histone acetylation and globin gene switching
27. CREB-binding protein (CBP) acetylates hematopoietic transcription factor GATA-1 at functionally important sites
28. Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation
29. Activation of transcription by PU.1 requires both acidic and glutamine domains
30. Cell cycle-regulated histone acetylation required for expression of the yeast HO gene
31. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts
32. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP
33. Gen4 activator targets Gcn5 histone acetyltransferase to specific promoters independently of transcription
34. Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor
35. p300 stimulates transcription instigated by ligand-bound thyroid hormone receptor at a step subsequent to chromatin disruption
36. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage
37. A novel Rb- and p300-binding protein inhibits transactivation by MyoD
38. Twist is a potential oncogene that inhibits apoptosis
39. The acetyltransferase activity of CBP stimulates transcription
40. Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines
41. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
42. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1
43. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with Krüppel family proteins Sp1 and EKLF
44. Fusion of the nuclear oncoproteins v-Myb and v-Ets is required for the leukemogenicity of E26 virus
45. Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene
46. Tumors in Rubinstein-Taybi syndrome
47. Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle
48. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
49. Spi-1/PU.1: An oncogene of the Ets family
50. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias
51. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias
52. The world according to Maf
53. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors
54. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription
55. The ets sequence is required for induction of erythroblastosis in chickens by avian retrovirus E26
56. The transcriptional coactivators p300 and CBP are histone acetyltransferases
57. Factor-specific modulation of CREB-binding protein acetyltransferase activity
58. A two-step mechanism for recruitment of Pip by PU.1
59. Conserved elements containing NF-E2 and tandem GATA binding sites are required for erythroid-specific chromatin structure reorganization within the human β-globin locus control region
60. PU.1 can participate in an active enhancer complex without its transcriptional activation domain
61. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity
62. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation
63. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: Functional antagonism in erythroid cells
64. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
65. DNA damage activates p53 through a phosphorylation-acetylation cascade
66. Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter
67. Nuclear localization and histone acetylation: A pathway for chromatin opening and transcriptional activation of the human beta-globin locus
68. Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells
69. The Ets-related transcription factor PU.1 immortalizes erythroblasts
70. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein
71. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
72. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein
73. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
74. Inhibitory interaction of c-Myb and GATA-1 via transcriptional coactivator CBP
75. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation
76. Inhibition of hematopoiesis by competitive binding of transcription factor PU.1
77. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1-embryonic stem cells
78. GATA transcription factors: Key regulators of hematopoiesis
79. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis
80. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells
81. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells
82. Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP
83. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1
84. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding
85. Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases
86. Site-specific acetylation by p300 or CREB binding protein regulates erythroid Kruppel-like factor transcriptional activity via its interaction with the SWI-SNF complex